Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Henk Hoeksema is active.

Publication


Featured researches published by Henk Hoeksema.


Burns | 2009

Accuracy of early burn depth assessment by laser Doppler imaging on different days post burn

Henk Hoeksema; Karlien Van de Sijpe; Thierry Tondu; Moustapha Hamdi; Koenraad Van Landuyt; Phillip Blondeel; Stan Monstrey

BACKGROUND Accurate diagnosis of burn depth is essential in selecting the most appropriate treatment. Early assessment of burn depth by clinical means only has been shown to be inaccurate, resulting in unnecessary operations or delay of grafting procedures. Laser Doppler imaging (LDI) was reported as an objective technique to determine the depth of a burn wound, but the accuracy on very early days post burn has never been investigated yet. METHODS In 40 patients with intermediate depth burns, we prospectively evaluated and compared the accuracy of the LDI measurements with the clinical assessments on days 0, 1, 3, 5, 8. Clinical evaluation of the depth of the burn was performed by two observers blinded to the LDI images. Accuracies were assessed by comparison with outcome: healing times longer than 21 days were considered to be equivalent to a biopsy finding of a deep dermal wound. Obviously superficial and full thickness wounds were excluded. LDI flux level was used for LDI prediction of outcome: less than 220PU to predict non-healing at day 21. RESULTS The accuracies of burn depth assessments on the day of burn and post burn days 0, 1, 3, 5 and 8 using LDI were 54%, 79.5%, 95%, 97% and 100% compared with clinical assessment accuracies of 40.6%, 61.5%, 52.5%, 71.4% and 100%, respectively. LDI accuracy was significantly higher than clinical accuracy on day 3 (p<0.001) and day 5 (p=0.005). Burn depth conversion was also considered. This is the first study to quantify the advantage of LDI scanning over clinical assessments during these important early after burn days.


Journal of Trauma-injury Infection and Critical Care | 2010

Skin replacement in burn wounds.

Nele Brusselaers; Ali Pirayesh; Henk Hoeksema; C. D. Richters; Jozef Verbelen; Hilde Beele; Stijn Blot; Stan Monstrey

Historically, the main goal in burn management was increasing the survival of severely burned patients by rapid debridement and early closure of burn wounds, consequently reducing the infection risk.1–4 However, in the last decennia, surgical emphasis has shifted from survival to “quality of survival,” especially by improving the residual scars and preventing contractures. Traditionally, surgeons divide burns into deep burns requiring surgical therapy, and superficial burns which heal spontaneous by re-epithelialization with minimal scarring. Nevertheless, there is a gray zone between those two groups in which therapeutic decision making is difficult. The final decision for surgery generally remains case and surgeon dependent, and will mainly depend on the total burned surface area.5 Wound closure can be obtained by diverse therapeutic modalities depending on the depth and healing potential of the burn wound.5 In this article, the main focus is on the surgical treatment of deep dermal and full thickness burns. We endeavor to give a comprehensive overview of the developments in skin substitutes, which is impossible without mentioning some alternative treatments. The current golden standard for deep burns is surgical debridement and closure with autologous split thickness skin grafts or “STG” (epidermis plus a thin layer of dermis). Nevertheless, donor areas are limited in extended burns, and the residual scars remain unsatisfactory due to the lack of dermis. A more aesthetical reconstruction can be obtained with full thickness skin grafts (epidermis and whole dermis), which are limited in dimension and can only be harvested in a few areas (groin, lower abdomen, etc.). Deep defects with exposed bone or neurovascular structures are currently treated with flap surgery, which gives an optimal aesthetical and functional result. Nevertheless, the severe donor-site morbidity, the technical difficulty, and sometimes severe complications limit its use mostly to secondary reconstructions. Consequently, alternative conservative and surgical treatments were developed to improve the healing and the quality of the residual scars.6 Several mechanisms are supposed to enhance healing: (i) providing the ideal wound environment (wound dressings, etc.), (ii) by assisting the intrinsic healing capacities (growth factors, cytokines, etc.), or (iii) by surgically replacing the damaged skin (“skin substitutes”), which also should reduce scarring in full thickness defects. A permanent skin substitute is a surgically fixated “long lasting” skin replacement, consisting of naturally occurring skin elements which become incorporated in the normal skin. The main issue of this definition is the longevity of a skin substitute, which seems to be mostly of commercial importance, where terms such as biological dressings, and permanent and temporary skin substitutes are used without a clear distinction. This literature review showed that technically similar products are commercialized as “permanent” by one company and as biological dressing by another. Therefore, we chose to divide all these products in the following categories, depending on the skin layer which is (temporary) replaced: epidermal, dermal and combined skin substitutes (or composite grafts; Fig. 1). In the future, a fourth group might need to be added: the combined skin substitute with a subcutaneous adipose layer.7 However, the difference between skin replacements and some wound dressings can be small. Wound dressings are intended for coverage instead of replacement, to optimize wound healing. Wound dressings can roughly be divided in dressings containing natural elements (such as honey ointments), synthetic dressings (such as silver-impregnated dressings), and biological dressings containing mammalian cells or cell-derived substances like collagens and growth factors (human donor skin). Synthetically manufactured, naturally occurring elements, such as cellulose membranes, are also synthetic dressings. Wound dressings are not considered as (permanent) skin substitutes because they are not incorporated in the healing wound. Some authors previously named some of these products “skin substitutes” (without mentioning “permanent”) but this only lead to confusing terminology. The most important biological dressing, used since the 1940s, is human donor skin or “cadaver skin.”8 It contains several beneficial factors (growth factors, cytokines, etc.), and it provides the ideal environment for healing. Because of better preservation techniques (glycerol or cryopreserved), the risk of infection transmission is minimized, and its rejection will be delayed up to 3 weeks to 5 weeks.8,9 One of the Submitted for publication May 18, 2009. Accepted for publication November 6, 2009. Copyright


Revue Francophone de Cicatrisation | 2017

Dressilk®: a series of case reports on partial thickness burns and donor sites

Jozef Verbelen; Henk Hoeksema; Kris De Meyere; Stan Monstrey

this area Do not cover this area Do not cover this area Do not cover this area Do not cover this area Do not cover this area. Index The management of both split thickness donor sites and partial thickness burns with healing potential within 21 days is often considered to be similar. Dressilk®, a dressing consisting of 100% silk, is a promising treatment option. DRESSILK®: A SERIES OF CASE REPORTS ON PARTIAL THICKNESS BURNS AND DONOR SITES


International Journal of Artificial Organs | 2015

Development of chemically cross-linked biopolymer based burn wound dressings with antimicrobial properties

Birgit Stubbe; Mohaddeseh Amiri Aref; Henk Hoeksema; Frank Vanhaecke; Stan Monstrey; Piet Van Espen; Karolien De Wael; Sandra Van Vlierberghe; Peter Dubruel

Abstracts from the XLII Congress of the European Society for Artificial Organs, 2-5 September 2015, Leuven, Belgium.


Cell and Tissue Banking | 2008

Development of a dermal matrix from glycerol preserved allogeneic skin.

C. D. Richters; Ali Pirayesh; Henk Hoeksema; E.W.A. Kamperdijk; R Kreis; R.P. Dutrieux; Stan Monstrey; Mj Hoekstra


BMC Medical Research Methodology | 2009

Using ordinal logistic regression to evaluate the performance of laser-Doppler predictions of burn-healing time

Rose Baker; Christian Weinand; James C. Jeng; Henk Hoeksema; Stan Monstrey; Sarah A. Pape; Robert J. Spence; David Wilson


Archive | 2010

RESEARCH REVIEW Burn Scar Assessment: A Systematic Review of Different Scar Scales

Nele Brusselaers; A. Pirayesh; Henk Hoeksema; Jozef Verbelen; Stijn Blot; Stan Monstrey


Wound Repair and Regeneration | 2008

Development of a novel dermal substitute based on glycerinised allograft

Ali Pirayesh; C. D. Richters; Henk Hoeksema; Jo Vanoorbeek; Harm Hoekstra; Stan Monstrey


Revue Francophone de Cicatrisation | 2017

Chemical Injury: 4 years of experience with an advanced research approach

Jozef Verbelen; Henk Hoeksema; Kris De Meyere; Stan Monstrey


Revue Francophone de Cicatrisation | 2017

UWT/OC05 - Dressilk®: a series of case reports on partial thickness burns and donor sites

Jozef Verbelen; Henk Hoeksema; Kris De Meyere; Stan Monstrey

Collaboration


Dive into the Henk Hoeksema's collaboration.

Top Co-Authors

Avatar

Stan Monstrey

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jozef Verbelen

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar

Ali Pirayesh

Ghent University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge